Stock

UK’s CMA may accept Synopsys/Ansys deal remedies

Investing.com — The UK’s Competition and Markets Authority (CMA) said it may accept the remedies offered by Synopsys (NASDAQ:SNPS) and Ansys (NASDAQ:ANSS). The agency now has until until March 5, 2025 to make an official decision. The undertakings, offered by both companies at the end of last year on December 31, include the divestment of certain product lines.

Specifically, Ansys has proposed to divest its product for power consumption analysis of digital chips. On the other hand, Synopsys has offered to divest its Optical Solutions Group. The CMA has stated that there are reasonable grounds to believe that these undertakings might be accepted.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.